August 31, 2026 Palo Alto Networks Reports Tuesday Tuesday’s Q4 report is the first full quarter with both CyberArk and…
The Browser Is the Breach
Infostealers are feeding ransomware, and remote work is the soft spot.
Nvidia says without this radical device AI can’t scale
August 31, 2026 This tiny piece of glass could be bigger than GPUs Bonus Content: One Chip Market, Two Different…
Myqorzo’s Balance Sheet Meets Its Biggest Catalyst
With $1.7B in cash and a Q4 sNDA plan, Cytokinetics just validated a major untreated corner of HCM.
Marvell’s FY28 Is Now $18B.
August 30, 2026 Marvell’s FY28 Is Now $18B. Record revenue, two straight guidance raises. Analyst Targets Rosenblatt Securities: Buy, PT…
When Your Supplier Is Also Your Enemy
The Cursor cutoff reveals a first principle every long-term investor must stress-test: you do not own a franchise if a…
Buy This Stock Tomorrow Morning
August 30, 2026 Bonus Content: Off-Price Wins the Week. BURL Has to Prove It. Sponsored Dear Reader, I’ve just revealed…
AVGO Reports Wednesday. The $16B Line Is the Only One That Matters.
Broadcom's fiscal Q3 results land Sept. 2, with AI semiconductor revenue guidance at a make-or-break level.
Lenacapavir Is Now a Platform. Is GILD Priced for It?
Bixlenvo's approval reframes the LOE debate, and the multiple may not yet reflect what lenacapavir is becoming.
Trump Targets Meat Monopoly
August 29, 2026 A Truth Social post rattled TSN and JBS Analyst Targets Barclays: Buy, $80.00 target J.P. Morgan: Hold…
